Efficacy of narrow-band imaging as an additional tool in carcinoma urinary bladder
Not Applicable
Recruiting
- Conditions
- Health Condition 1: C679- Malignant neoplasm of bladder, unspecified
- Registration Number
- CTRI/2020/05/024988
- Lead Sponsor
- AIIMS Bhubaneswar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients clinically diagnosed as Carcinoma Bladder and undergoing Endoscopic Therapy
Exclusion Criteria
a) Active Urinary Tract Infection
b) Gross hematuria that interferes with cystoscopy during Endoscopic therapy
c) Bleeding diathesis
d) Benign tumor
e) High volume tumor not completely resected with Endoscopic therapy
f) Muscle-invasive tumors
g) Those receiving Chemotherapy or Radiotherapy
h) Non-urothelial carcinoma
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) To find the efficacy of detection of additional malignant lesions by Narrow Band Imaging after Endoscopic Therapy of Transitional Cell Carcinoma of Urinary Bladder under White Light <br/ ><br>2) To catalogue visual characteristics that predict malignancy using Narrow Band ImagingTimepoint: Approximately 10 days from the day of surgery (until the histopathology report is available)
- Secondary Outcome Measures
Name Time Method To observe for recurrence after using Narrow Band Imaging after Endoscopic Therapy of Transitional Cell Carcinoma of Urinary BladderTimepoint: 1 year follow up from the day of surgery